Table of Contents
A probability-based national survey conducted from December 2023 to January 2024 estimates that at least 8.4 million U.S. adults have microdosed psilocybin in their lifetime. Among recent users, roughly half reported microdosing at last use, and improved mental or physical health was the dominant stated motivation.
- Microdosing is common among psilocybin users: Among U.S. adults who used psilocybin in the past year, nearly half said their last use was a microdose rather than a full dose.
- Health is the primary driver: People who microdosed were 25 percentage points more likely to cite mental health improvement as a reason for use compared with those who did not microdose, and 12 points more likely to cite physical health improvement.
- Recreational motivation is much lower among microdosers: Those who microdosed were 27 percentage points less likely to report using psilocybin for fun or pleasure than non-microdosers.
- Awareness gaps exist: About 15 percent of lifetime psilocybin users were unsure whether they had actually microdosed, pointing to a real need for clearer public education on what microdosing means.
- Model
- Human (U.S. adult population survey)
- Sample
- 4,253 screener respondents; 554 lifetime psilocybin users identified
- Dose
- Self-reported; microdosing defined as a fraction of a regular dose
- Design
- Probability-based, nationally representative cross-sectional survey; multinomial logit models for predictors
- Key outcome
- An estimated 8.4 million U.S. adults have microdosed psilocybin in their lifetime; health improvement is the top stated motivation
- Main limitation
- Self-report data; approximately 15% of lifetime users were unsure whether they had microdosed
What the Research Examined
This is a nationally representative, probability-based survey study fielded by RAND from December 2023 to January 2024. Of 4,253 people who completed an initial screener, 554 reported lifetime psilocybin use. The researchers applied sample weights to produce population-level estimates and used multinomial logit models to identify which demographic characteristics predicted microdosing status. The full publication is available through the RAND external publication series.
The survey found that 12.1 percent of U.S. adults reported using psilocybin at least once in their lifetime. Among those lifetime users, 26.5 percent said they microdosed the last time they used. That share rose considerably among more recent users: among adults who used psilocybin in the past year, 46.9 percent reported their last use was a microdose, compared with 45.6 percent who said it was not. Those who microdosed were substantially more likely to cite mental and physical health reasons for their use, and substantially less likely to cite fun or pleasure.
For anyone exploring what we know about microdosing psilocybin, this survey offers the clearest population-level snapshot to date of how many Americans are engaging in the practice and what motivates them. The authors note an important caveat: roughly 15 percent of lifetime users did not know whether they had microdosed, which suggests that a shared, understood definition of the term has not yet reached much of the public.
What the Findings Show
- Lifetime microdosers (population estimate).At least 8.4 million U.S. adults are estimated to have microdosed psilocybin in their lifetime.
- Microdosing rate among past-year users.46.9% of adults who used psilocybin in the past year reported that their last use was a microdose (95% CI: 35.3 to 58.8).
- Mental health motivation gap.Microdosers were 25 percentage points more likely (p less than 0.001) to report using psilocybin for improved mental health, including to address substance use disorders, than non-microdosers.
- Recreational motivation gap.Microdosers were 27 percentage points less likely (p less than 0.001) to cite fun or pleasure as a reason for use compared with those who did not microdose.
One pattern worth holding carefully is the recency effect: adults who had used psilocybin within the past year were 25 percentage points more likely to report microdosing than those whose last use was more than a year prior. This could reflect growing cultural familiarity with the practice, a shift in the population of people drawn to psilocybin, or both. The survey design cannot distinguish between these possibilities.
How many Americans microdose psilocybin and why do they do it?
A 2023 to 2024 national survey estimates at least 8.4 million U.S. adults have microdosed psilocybin in their lifetime. Among those who used psilocybin in the past year, nearly half said their last use was a microdose, and improved mental or physical health was the most commonly stated reason.
What This Is, and What It Is Not
This is This is a self-reported, cross-sectional survey, which means it captures what people recall and choose to disclose at one point in time, and cannot establish cause and effect.
This is not This survey is not a clinical trial and does not demonstrate that microdosing produces health benefits. It does not establish a safe or effective dose, and nothing here should be read as medical advice or encouragement to use a controlled substance.
Our Take
From where we stand in this community, the numbers carry a quiet significance. Millions of people are quietly, intentionally turning to sub-perceptual doses of psilocybin not for escape, but in search of healing. That motivation, the orientation toward wholeness rather than pleasure, resonates with how the sacrament has been honored in many traditions across time. Science is now beginning to map a landscape that many have been navigating in private for years. These data do not tell us whether microdosing works; that question belongs to clinical research still underway. But they do tell us that this is a serious practice engaged in seriously, and that conversation deserves to be had openly, rigorously, and with care.
If you find yourself curious about the intentional, health-oriented relationship with psilocybin that these survey respondents described, we welcome you to explore further here. Whether you are at the Grounding station, just beginning to understand what this path involves, or somewhere deeper in your own process of Integration, this community exists to help you move with honesty and discernment. Read, ask questions, and take your time.
Frequently Asked Questions
What does microdosing psilocybin mean?
Microdosing refers to taking a fraction of a full psychedelic dose, typically small enough that it does not produce overt perceptual effects. The RAND survey used participants’ self-reported understanding of the term, and about 15 percent of lifetime users were unsure whether they had microdosed.
How many Americans have microdosed psilocybin?
The RAND survey, fielded in late 2023 and early 2024, estimates that at least 8.4 million U.S. adults have microdosed psilocybin at least once in their lifetime, based on a nationally representative sample with applied population weights.
Why do people microdose psilocybin?
According to this survey, improved mental health, including addressing substance use disorders, and improved physical health are the top stated motivations among U.S. adult microdosers. Microdosers were significantly less likely than non-microdosers to cite fun or pleasure as a reason.
Is microdosing psilocybin proven to improve mental health?
No. This survey records what people say motivates them; it does not measure health outcomes. Clinical trials are still needed to determine whether microdosing produces measurable mental health benefits, and psilocybin remains a federally controlled substance in the United States.
Who is more likely to microdose psilocybin?
The RAND survey found that people who used psilocybin more recently, within the past year, were 25 percentage points more likely to report microdosing than those whose last use was more than a year ago. The study used demographic models but did not single out one group as the typical microdoser.
Get the Mycelium Report
We read the new psilocybin and mushroom research so you do not have to. One honest, jargon-free dispatch, delivered daily. Free to join.
May love guide the hearts of all beings.
